IP

IPO: BLLN

YC S17

San Francisco, US · Founded 2016 · 300 employees · Public · 7 known investors

billiontoone.com ↗

BillionToOne is a precision diagnostics company that uses molecular counting technology to develop non-invasive prenatal screening and liquid biopsy tests for early disease detection. The company focuses on making molecular diagnostics accurate, fast, and accessible to patients.

Founders & leadership· Y Combinator alumni (S17)

OA

Oguzhan Atay, PhDCo-Founder, CEO, and Board Chair

DT

David Tsao, PhDCo-Founder, CTO, and Board Member

Oguzhan AtayinFounder

David TsaoinFounder/CTO

Investors · 7

CI

Civilization Ventures Management, LlcTiburon · $1M

FI

Fifty YearsSan Francisco

FR

FrialeNashville

HU

Hummingbird VenturesBelgium

TO

Toba Capital

UP

UpHonest CapitalPalo Alto

Y

Y CombinatorSan Francisco · $500K – $500K